DA Davidson raised the firm’s price target on Trustmark to $34 from $30 and keeps a Neutral rating on the shares. The company’s sale of its insurance agency highlighted an otherwise “solid” quarter, with sequential quarter growth also supported by increased gain on sale, lower MSR amortization, and reduced hedging ineffectiveness, the analyst tells investors in a research note.